Middle East and Africa Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others) 

Code: BMIRE00024998 | Pages: 167 | Industry: Pharmaceuticals | Date: Jun 2022 | Type: Regional

The generic injectables market in the Middle East & Africa is expected to grow from US$ 3,717.72 million in 2021 to US$ 6,616.77 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028.

The patents of branded injectables in several countries are likely to expire in the coming years, offering numerous remunerative opportunities to the generic injectables manufacturers. Additionally, manufacturers in the generic injectables market are becoming future-ready by maintaining adequate supply chains to prevent vulnerabilities, such as those caused by the COVID-19 outbreak. Zydus Cadila is significantly reducing the price of its generic version of Remdesivir, namely Remdac. Thus, the nearing expiry of patent validity of branded drugs is likely to provide significant opportunities to generic drug manufacturers, including the companies offering generic injectables.

Middle East & Africa Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


Middle East & Africa Generic Injectables Market Segmentation

The Middle East & Africa generic injectables market is segmented into product type, container type, application, route of administration, and country. Based on product type, the market has been segmented into large molecule injectable and small molecule injectable. In 2020, the large molecule injectable segment held a larger market share. In terms of container type, the market has been categorized into vials, premix, prefilled syringes, ampoules, and others. In 2020, the vials segment held the largest share of the market. Based on application, the market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, and others. In 2020, the oncology segment held the largest share of the market. Based on route of administration, the market has been categorized into intravenous, intramuscular, subcutaneous, and others. In 2020, the intravenous segment held the largest market share. Based on country, the Middle East & Africa generic injectables market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia contributed a substantial share in 2020. 

AstraZeneca; Baxter International Inc.; Biocon; Fresenius SE & Co. KGaA; GlaxoSmithKline plc; Hikma Pharmaceuticals PLC; Johnson and Johnson Services, Inc.; Lupin; Merck & Co., Inc.; Pfizer Inc.; and Viatris Inc are among the leading companies in the Middle East & Africa generic injectables market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Generic injectables Market – By Product Type

1.3.2        MEA Generic injectables Market – By Container Type

1.3.3        MEA Generic injectables Market – By Application

1.3.4        MEA Generic injectables Market – By Route of Administration

1.3.5        MEA Generic injectables Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Generic Injectables Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Generic Injectables Market Key Market Dynamics

5.1         Market Drivers

5.1.1        Low R&D, Marketing, and Manufacturing Costs

5.1.2        Surging Demand for Affordable Drugs

5.2         Market Restraints

5.2.1        Critical Inspection System for Prefilled Injection

5.3         Market Opportunities

5.3.1        Increasing Patent Expiry of Drugs

5.4         Future Trends

5.4.1        Government Support for Generic Injectables Production and Healthcare Cost Reduction

5.5         Impact Analysis

6.           Generic Injectables Market– MEA Analysis

6.1         MEA Generic Injectables Market Revenue Forecast and Analysis

7.           MEA Generic Injectables Market– by Product Type

7.1         Overview

7.2         MEA Generic Injectables Market, By Product Type, 2021 & 2028 (%)

7.3         Large Molecule Injectables

7.3.1        Overview

7.3.2        Large Molecule Injectables: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

7.4         Small Molecule Injectables

7.4.1        Overview

7.4.2        Small Molecule Injectables: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.           MEA Generic Injectables Market– by Container Type

8.1         Overview

8.2         MEA Generic Injectables Market, By Container Type, 2021 & 2028 (%)

8.3         Vials

8.3.1        Overview

8.3.2        Vials: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.4         Premix

8.4.1        Overview

8.4.2        Premix: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.5         Prefilled Syringes

8.5.1        Overview

8.5.2        Prefilled Syringes: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.6         Ampoules

8.6.1        Overview

8.6.2        Ampoules: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.           MEA Generic Injectables Market– by Application

9.1         Overview

9.2         MEA Generic Injectables Market, By Application, 2021 & 2028 (%)

9.3         Oncology

9.3.1        Overview

9.3.2        Oncology: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.4         Infectious Diseases

9.4.1        Overview

9.4.2        Infectious Diseases: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.5         Cardiology

9.5.1        Overview

9.5.2        Cardiology: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.6         Diabetes

9.6.1        Overview

9.6.2        Diabetes: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.7         Immunology

9.7.1        Overview

9.7.2        Immunology: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.8         Others

9.8.1        Overview

9.8.2        Others: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.        MEA Generic Injectables Market–by Route of Administration

10.1      Overview

10.2      MEA Generic Injectables Market, By Route of Administration, 2021 & 2028 (%)

10.3      Intravenous

10.3.1     Overview

10.3.2     Intravenous: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.4      Intramuscular

10.4.1     Overview

10.4.2     Intramuscular: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.5      Subcutaneous

10.5.1     Overview

10.5.2     Subcutaneous: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

11.        MEA Generic Injectables Market– Country Analysis

11.1      MEA: Generic Injectables Market

11.1.1     Overview

11.1.2     MEA: Generic Injectables Market, by Country, 2021 & 2028 (%)

11.1.2.1       Saudi Arabia: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1       Saudi Arabia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2       Saudi Arabia Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.3       Saudi Arabia: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.2.1.4       Saudi Arabia: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.2.1.5       Saudi Arabia: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.2       UAE: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1       UAE: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2       UAE Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.3       UAE: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.2.2.4       UAE: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.2.2.5       UAE: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.3       South Africa: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1       South Africa: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2       South Africa Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.3       South Africa: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.2.3.4       South Africa: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.2.3.5       South Africa: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.4       Rest of MEA: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)

11.1.2.4.1       Rest of MEA: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)

11.1.2.4.2       Rest of MEA Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.4.3       Rest of MEA: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.2.4.4       Rest of MEA: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.2.4.5       Rest of MEA: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

12.        MEA Generic Injectables Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      AstraZeneca

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Baxter International Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Biocon

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Fresenius SE & Co. KGaA

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      GlaxoSmithKline plc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Hikma Pharmaceuticals PLC

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Johnson and Johnson Services, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Lupin

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Viatris Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Merck & Co., Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Pfizer Inc.

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             MEA Generic injectables Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 6.             UAE Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             UAE Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             UAE Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 9.             UAE Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 10.          South Africa Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          South Africa Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Africa Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of MEA Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of MEA Generic Injectables Market, by Container Type– Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of MEA Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of MEA Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 18.          Organic Developments Done By Companies

Table 19.          Inorganic Developments Done By Companies

Table 20.          Glossary of Terms, MEA Generic Injectables Market

 


LIST OF FIGURES

Figure 1.           MEA Generic injectables Market Segmentation

Figure 2.           MEA Generic injectables Market, By Country

Figure 3.           MEA Generic Injectables Market Overview

Figure 4.           Large Molecule Injectable Segment Held Largest Share of Product Type Segment in MEA Generic injectables Market

Figure 5.           UAE is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           MEA: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           MEA Generic injectables Market Impact Analysis of Driver and Restraints

Figure 9.           MEA Generic injectables Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        MEA Generic Injectables Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Large Molecule Injectables: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Small Molecule Injectables: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        MEA Generic Injectables Market, by Container Type, 2021 & 2028 (%)

Figure 14.        Vials: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Premix: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Prefilled Syringes: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Ampoules: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Others: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        MEA Generic Injectables Market, by Application, 2021 & 2028 (%)

Figure 20.        Oncology: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Infectious Diseases: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Cardiology: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diabetes: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Immunology: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Others: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        MEA Generic Injectables Market, by Route of Administration, 2021 & 2028 (%)

Figure 27.        Intravenous: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Intramuscular: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Subcutaneous: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Others: MEA Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        MEA: Generic Injectables Market, by Key Country – Revenue (2021) (USD Million)

Figure 32.        MEA: Generic Injectables Market, by Country, 2021 & 2028 (%)

Figure 33.        Saudi Arabia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        UAE: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        South Africa: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        Rest of MEA: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)

  1. AstraZeneca
  2. Baxter International Inc.
  3. Biocon
  4. Fresenius SE & Co. KGaA
  5. GlaxoSmithKline plc
  6. Hikma Pharmaceuticals PLC
  7. Johnson and Johnson Services, Inc.
  8. Lupin
  9. Merck & Co., Inc.
  10. Pfizer Inc.
  11. Viatris Inc
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000